Notable insider trades include Schobel Alexander Mark, Chief Innovation/Tech Officer at Aquestive Therapeutics Inc (AQST), who sold 50000 shares on Mar 15 ’24, at $6 each, totaling $0.30 million. On ...

Envista Holdings Corp (NVST) stock saw a decline, ending the day at $19.17 which represents a decrease of $-0.32 or -1.64% from the prior close of $19.49. The stock opened at $19.42 and touched a low ...

Nonfarm payrolls increased by 256,000 jobs last month after rising by a downwardly revised 212,000 in November, while the unemployment rate fell to 4.1% from 4.2%, Reuters reported this morning.

Walgreens Boots Alliance beat analysts' lowered expectations for first-quarter profit and maintained its annual forecast on ...

On second thought, the FDA figures it no longer needs to discuss Exelixis’ application for Cabometyx in neuroendocrine tumors ...

Walgreens Boots Alliance beat analysts' lowered expectations for first-quarter adjusted profit and maintained its annual ...

Pharmaceuticals announced that it has commenced an underwritten public offering of shares of its common stock. Amylyx intends to ...

Uniqure N.V. (NASDAQ: QURE) has announced the pricing of its public offering of 4,411,764 ordinary shares at a price of ...

Despite a $265 million net loss, investors saw reason for optimism in the quarter, including renegotiated pharmacy contracts ...

Stock analysts at Leerink Partnrs decreased their Q4 2025 earnings per share (EPS) estimates for Illumina in a note issued to ...

Equities researchers at Leerink Partnrs lifted their Q1 2025 earnings estimates for Illumina in a report released on Tuesday, ...

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) ("Amylyx" or the "Company") today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares are being ...